{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:20:45Z","timestamp":1780453245112,"version":"3.54.1"},"reference-count":36,"publisher":"Japanese Pharmacological Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1254\/jphs.13063fp","type":"journal-article","created":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T22:55:45Z","timestamp":1380840945000},"page":"147-158","source":"Crossref","is-referenced-by-count":9,"title":["New Screening System for Selective Blockers of Voltage-Gated K+ Channels Using Recombinant Cell Lines Dying Upon Single Action Potential"],"prefix":"10.1254","volume":"123","author":[{"given":"Masato","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Ohya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Castle NA. Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy. Expert Opin Ther Pat. 2010;20:1471\u20131503.","DOI":"10.1517\/13543776.2010.513384"},{"key":"2","unstructured":"2 Matheu MP, Beeton C, Garcia A, Chi V, Rangaraju S, Safrina O, et al. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity. 2008;29:602\u2013614."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Gaborit N, Le Bouter S, Szuts V, Varro A, Escande D, Nattel S, et al. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol. 2007;582:675\u2013693.","DOI":"10.1113\/jphysiol.2006.126714"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A. 2006;103:17414\u201317419.","DOI":"10.1073\/pnas.0605136103"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Ravens U, Wettwer E. Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications. Cardiovasc Res. 2011;89:776\u2013785.","DOI":"10.1093\/cvr\/cvq398"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Knobloch K, Brendel J, Peukert S, Rosenstein B, Busch AE, Wirth KJ. Electrophysiological and antiarrhythmic effects of the novel I<sub>Kur<\/sub> channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I<sub>Kr<\/sub> blockers dofetilide, azimilide, d,l-sotalol and ibutilide. Naunyn Schmiedebergs Arch Pharmacol. 2002;366:482\u2013487.","DOI":"10.1007\/s00210-002-0599-x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Yang XF, Yang Y, Lian YT, Wang ZH, Li XW, Cheng LX, et al. The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker. PLoS One. 2012;7:e36379.","DOI":"10.1371\/journal.pone.0036379"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov. 2009;8:982\u20131001.","DOI":"10.1038\/nrd2983"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Guthrie H, Livingston FS, Gubler U, Garippa R. A place for high-throughput electrophysiology in cardiac safety: screening hERG cell lines and novel compounds with the ion works HTTM system. J Biomol Screen. 2005;10:832\u2013840.","DOI":"10.1177\/1087057105280566"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Dale TJ, Townsend C, Hollands EC, Trezise DJ. Population patch clamp electrophysiology: a breakthrough technology for ion channel screening. Mol Biosyst. 2007;3:714\u2013722.","DOI":"10.1039\/b706152h"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Rezazadeh S, Hesketh JC, Fedida D. Rb<sup>+<\/sup> flux through hERG channels affects the potency of channel blocking drugs: correlation with data obtained using a high-throughput Rb+ efflux assay. J Biomol Screen. 2004;9:588\u2013597.","DOI":"10.1177\/1087057104264798"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Weaver CD, Harden D, Dworetzky SI, Robertson B, Knox RJ. A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells. J Biomol Screen. 2004;9:671\u2013677.","DOI":"10.1177\/1087057104268749"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Dorn A, Hermann F, Ebneth A, Bothmann H, Trube G, Christensen K, et al. Evaluation of a high-throughput fluorescence assay method for HERG potassium channel inhibition. J Biomol Screen. 2005;10:339\u2013347.","DOI":"10.1177\/1087057104272045"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Fujii M, Ohya S, Yamamura H, Imaizumi Y. Development of recombinant cell line co-expressing mutated Nav1.5, Kir2.1, and hERG for the safety assay of drug candidates. J Biomol Screen. 2012;17:773\u2013784.","DOI":"10.1177\/1087057112442102"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen. 1999;4:67\u201373.","DOI":"10.1177\/108705719900400206"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Garcia-Calvo M, Leonard RJ, Novick J, Stevens SP, Schmalhofer W, Kaczorowski GJ, et al. Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. J Biol Chem. 1993;268:18866\u201318874.","DOI":"10.1016\/S0021-9258(17)46707-X"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Lee HM, Hahn SJ, Choi BH. Open channel block of Kv1.5 currents by citalopram. Acta Pharmacol Sin. 2010;31:429\u2013435.","DOI":"10.1038\/aps.2010.14"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Wu HJ, Wu W, Sun HY, Qin GW, Wang HB, Wang P, et al. Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain. J Mol Cell Cardiol. 2011;51:966\u2013973.","DOI":"10.1016\/j.yjmcc.2011.08.022"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Coetzee WA, Amarillo Y, Chiu J, Chow A, Lau D, McCormack T, et al. Molecular diversity of K<sup>+<\/sup> channels. Ann N Y Acad Sci. 1999;868:233\u2013285.","DOI":"10.1111\/j.1749-6632.1999.tb11293.x"},{"key":"20","unstructured":"20 Grissmer S, Nguyen AN, Aiyar J, Hanson DC, Mather RJ, Gutman GA, et al. Pharmacological characterization of five cloned voltage-gated K<sup>+<\/sup> channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol. 1994;45:1227\u20131234."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Pan MH, Lai CS, Wang YJ, Ho CT. Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Biochem Pharmacol. 2006;72:1293\u20131303.","DOI":"10.1016\/j.bcp.2006.07.039"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Cholbi MR, Paya M, Alcaraz MJ. Inhibitory effects of phenolic compounds on CCl4-induced microsomal lipid peroxidation. Experientia. 1991;47:195\u2013199.","DOI":"10.1007\/BF01945426"},{"key":"23","unstructured":"23 Watanabe K, Kanno S, Tomizawa A, Yomogida S, Ishikawa M. Acacetin induces apoptosis in human T cell leukemia Jurkat cells via activation of a caspase cascade. Oncol Rep. 2012;27:204\u2013209."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Shim HY, Park JH, Paik HD, Nah SY, Kim DS, Han YS. Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK\/JNK1\/2-c-Jun activation. Mol Cells. 2007;24:95\u2013104.","DOI":"10.1016\/S1016-8478(23)10760-6"},{"key":"25","unstructured":"25 Bezchlibnyk-Butler K, Aleksic I, Kennedy SH. Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci. 2000;25:241\u2013254."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Waring WS. Clinical use of antidepressant therapy and associated cardiovascular risk. Drug Healthc Patient Saf. 2012;4:93\u2013101.","DOI":"10.2147\/DHPS.S28804"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Vicente R, Escalada A, Villalonga N, Texido L, Roura-Ferrer M, Martin-Satue M, et al. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J Biol Chem. 2006;281:37675\u201337685.","DOI":"10.1074\/jbc.M605617200"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Pacher P, Bagi Z, Lako-Futo Z, Ungvari Z, Nanasi PP, Kecskemeti V. Cardiac electrophysiological effects of citalopram in guinea pig papillary muscle comparison with clomipramine. Gen Pharmacol. 2000;34:17\u201323.","DOI":"10.1016\/S0306-3623(99)00048-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Pousti A, Malihi G, Naghibi B. Effect of citalopram on ouabain-induced arrhythmia in isolated guinea-pig atria. Hum Psychopharmacol. 2003;18:121\u2013124.","DOI":"10.1002\/hup.446"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Pincin C, Ferrera L, Moran O. Minimal sodium channel pore consisting of S5-P-S6 segments preserves intracellular pharmacology. Biochem Biophys Res Commun. 2005;334:140\u2013144.","DOI":"10.1016\/j.bbrc.2005.06.068"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Takahashi S, Shibata M, Fukuuchi Y. Role of sodium ion influx in depolarization-induced neuronal cell death by high KCI or veratridine. Eur J Pharmacol. 1999;372:297\u2013304.","DOI":"10.1016\/S0014-2999(99)00208-3"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Dunlop J, Bowlby M, Peri R, Vasilyev D, Arias R. High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology. Nat Rev Drug Discov. 2008;7:358\u2013368.","DOI":"10.1038\/nrd2552"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Slack M, Kirchhoff C, Moller C, Winkler D, Netzer R. Identification of novel Kv1.3 blockers using a fluorescent cell-based ion channel assay. J Biomol Screen. 2006;11:57\u201364.","DOI":"10.1177\/1087057105282712"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Singleton DH, Boyd H, Steidl-Nichols JV, Deacon M, Groot MJ, Price D, et al. Fluorescently labeled analogues of dofetilide as high-affinity fluorescence polarization ligands for the human ether-a-go-go-related gene (hERG) channel. J Med Chem. 2007;50:2931\u20132941.","DOI":"10.1021\/jm0700565"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Liu K, Samuel M, Tillett J, Hennan JK, Mekonnen B, Soloveva V, et al. High-throughput screening for Kv1.3 channel blockers using an improved FLIPR-based membrane-potential assay. J Biomol Screen. 2010;15:185\u2013195.","DOI":"10.1177\/1087057109356209"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Huang CJ, Harootunian A, Maher MP, Quan C, Raj CD, McCormack K, et al. Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential. Nat Biotechnol. 2006;24:439\u2013446.","DOI":"10.1038\/nbt1194"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/123\/2\/123_13063FP\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T11:43:28Z","timestamp":1716032608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/123\/2\/123_13063FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.13063fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}